Back to search results

Pro-social Power Training for Chronic Kidney Disease

This study is testing a 16-week program called "Pro-social Power training Activity for Aging and Well-being with Chronic Kidney Disease." This program involves power training and physical activity, with group sessions and individual at-home exercises, plus coaching. Another group will receive an education booklet and weekly check-in calls. The study is for Veterans with advanced chronic kidney disease who are considered "pre-frail" (meaning they have some signs of weakness or slowness). Researchers want to see if this program is practical and acceptable for participants. This is a pilot study, meaning it's a small first step to see if a larger study should be done in the future. Up to 30 Veterans will participate.

Study design
This is a randomized controlled pilot trial with up to 30 participants. Participants will be assigned by chance to either the active program or an attention control group.
What's involved
If you join the active program, you would meet 2-3 times per week for in-center power training for 16 weeks. The control group will receive an education booklet, use an accelerometer, and have weekly check-in calls.
Compensation
Not stated in the trial record.
Follow-up
Feasibility will be measured at 4 months after the start of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06089057

Pro-social Power Training Activity for Aging and Well-being With Chronic Kidney Disease

Enrolling by Invitation
NAAll AgesInterventionalHealth services
VA Office of Research and Development
~30 participants
Updated 2026-07-31 on ClinicalTrials.gov
What's tested:Pro-social Power training Activity for Aging and Well-being with Chronic Kidney DiseaseAttention Control for Pro-social Power training Activity for Aging and Well-being with Chronic Kidney Disease

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility, as measured by the questionnaire, the Feasibility of Intervention Measure
Measured over 4 months
+2 more outcomes measured

Conditions

Lower Extremity Muscle Strength

Explore related trials

Chronic Kidney Disease

NCT06089057

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Tennessee Valley Healthcare System Nashville Campus, Nashville, TN

    Nashville, Tennesseeno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Devika Nair, MD · PRINCIPAL_INVESTIGATOR · Tennessee Valley Healthcare System Nashville Campus, Nashville, TN

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participant's nephrologist and/or primary care physician agree that participant may enroll in trial
Participants classified as pre-frail per Fried Frailty phenotype due to slowness (time taken to walk 15 feet is greater than 6 seconds) in Aim 1, OR who report 'YES' to any of the following:
"For health or physical reasons, do you have difficulty in walking a mile (5-6 blocks)?", OR
"If no, have you changed the way you walk half a mile (5-6 blocks) because of underlying health problems?", OR
"For health or physical reasons, do you have difficulty in climbing 1 flight of stairs (10 steps)?", OR
"If no, have you changed the way you climb 1 flight of stairs (10 steps) because of health problems?"

Exclusion

Myocardial infarction or unstable angina within the prior six months based on electronic medical record review or self-report
Uncontrolled cardiac arrythmia within the prior six months based on electronic medical record review or self-report
Systolic blood pressure \> 180 mm Hg and/or diastolic blood pressure \> 110 mm Hg on more than one occasion within prior six months based on electronic medical record review or self-report
Cerebrovascular event and/or transient ischemic attack within prior six months based on electronic medical record review or self-report
Abnormal cardiac stress test within the past year based on electronic medical record review or self-report
Hemoglobin of 10 g/dL or less based on electronic medical record review or self-report
Class IV heart failure based on electronic medical record review or self-report
Dyspnea and/or chest pain at rest
Dependence on wheelchair for mobility
Permanent residence in nursing home or other long-term care facility
Terminal illness or other hospice-qualifying medical condition
Planned move away from middle Tennessee within the next year
Planned major surgery in the next six months
Blindness
Concurrent enrollment in physical therapy or structured exercise program
Anticipated dialysis or kidney transplant in upcoming three months
Non-English speaking
Severe cognitive impairment based on electronic medical record review or self-report

What this trial measures

  • Feasibility, as measured by the questionnaire, the Feasibility of Intervention Measure4 months

    This will be a brief questionnaire known as the Feasibility of Intervention Measure, that asks participants whether the intervention seems doable to them. There are four questions, and participants are asked to rate intervention feasibility from a scale of 1 (Strongly Disagree) to 5 (Strongly Agree). Scores range from 1-5 and are calculated as the mean of all scores. Higher scores indicate greater perceived feasibility. This will not be aggregated with any other measure.

  • Feasibility, as measured by a numerical percentage of all participants who consented out of those eligible4 months

    This will be a numeric percentage of participants who consent for the pilot trial out of all eligible participants in Aim 1. This will not be aggregated with any other measure.

  • Feasibility, as measured by a qualitative description of participants' reasons for declining4 months

    This will be a qualitative description of potential participants' reasons for declining, if applicable. This will not be aggregated with any other measure.